EX-CFR Director Makes $13.2M Deal In Insider Trading Suit
A former CFR Pharmaceuticals SA board member has agreed to pay $13.2 million to settle U.S. Securities and Exchange Commission allegations that he traded on insider information in Abbott Laboratories' $3.3...To view the full article, register now.
Already a subscriber? Click here to view full article